Long-term Survivors and Failures of CAR-T Therapy for Lymphoma: Is there a Role for Allogeneic Transplantation After the CAR-T Crash?

Transplant Cell Ther. 2023 Dec;29(12):725-726. doi: 10.1016/j.jtct.2023.11.003.

Authors

Michael A Spinner¹, Krishna V Komanduri¹

Affiliation

¹ Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.

PMID: 38035887
DOI: 10.1016/j.jtct.2023.11.003

No abstract available

MeSH terms

Humans
Immunotherapy, Adoptive
Lymphoma* / therapy
Receptors, Chimeric Antigen*
Survivors
Transplantation, Homologous

Substances

Receptors, Chimeric Antigen